TY - CHAP
T1 - Diabetes among māori and other ethnic groups in New Zealand
AU - Atlantis, Evan
AU - Joshy, Grace
AU - Williams, Margaret
AU - Simmons, David
N1 - Publisher Copyright:
© Springer International Publishing Switzerland 2017.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - The population of Aotearoa, New Zealand, has changed significantly since the signing of the Treaty of Waitangi between the indigenous people, Maori, and the British Crown in 1840. Several waves of immigration by Polynesians from various Pacific Islands since the 1960s and from Asia since the 1980s, along with migration by Maori into cities, have exposed these populations to Westernisation with resultant increases in obesity and type 2 diabetes. Since the early studies in the 1960s, Maori and Pacific peoples have been shown to experience two- to fourfold rates of type 2 diabetes as European New Zealanders, an excess now shown in Asian New Zealanders. Overall, Maori and the Pacific people have poorer blood glucose, blood pressure and blood lipid control with their diabetes. Associated with these are substantially higher rates of end-stage renal disease (with, e.g. up to 25-fold need renal replacement therapy among Maori), diabetic eye disease (including blindness), amputation and cardiovascular disease. Significant investment is clearly required into well-organised approaches that will reduce the incidence of type 2 diabetes, improve metabolic control and reduce the very high rates of diabetes complications that are now being seen.
AB - The population of Aotearoa, New Zealand, has changed significantly since the signing of the Treaty of Waitangi between the indigenous people, Maori, and the British Crown in 1840. Several waves of immigration by Polynesians from various Pacific Islands since the 1960s and from Asia since the 1980s, along with migration by Maori into cities, have exposed these populations to Westernisation with resultant increases in obesity and type 2 diabetes. Since the early studies in the 1960s, Maori and Pacific peoples have been shown to experience two- to fourfold rates of type 2 diabetes as European New Zealanders, an excess now shown in Asian New Zealanders. Overall, Maori and the Pacific people have poorer blood glucose, blood pressure and blood lipid control with their diabetes. Associated with these are substantially higher rates of end-stage renal disease (with, e.g. up to 25-fold need renal replacement therapy among Maori), diabetic eye disease (including blindness), amputation and cardiovascular disease. Significant investment is clearly required into well-organised approaches that will reduce the incidence of type 2 diabetes, improve metabolic control and reduce the very high rates of diabetes complications that are now being seen.
KW - Diabetes
KW - Ethnic
KW - Incidence
KW - Maori
KW - Native
KW - Pacific
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85009678143&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-41559-8_10
DO - 10.1007/978-3-319-41559-8_10
M3 - Chapter
SN - 9783319415574
SP - 165
EP - 190
BT - Diabetes Mellitus in Developing Countries and Underserved Communities
PB - Springer International Publishing Switzerland
ER -